1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Baseline clinical characteristics*

Combined (n = 16)IV rtPA (n = 13)P Value
Age (years, range)70 ± 8.8 (53–81)76 ± 10.2 (60–91).11
Sex (male/female)11/56/7.27
Baseline NIHSS score19 ± 2.216 ± 5.0.064
Early CT sign4 (25%)4 (31%)1
Lesion side (left/right)9/77/61
Blood pressure:
    Systolic (mm Hg)150 ± 20153 ± 19.67
    Diastolic (mm Hg)83 ± 1482 ± 13.86
Blood glucose (mg/dL)136 ± 40127 ± 31.51
Stroke subtype:
    Cardioembolic14 (87%)13 (100%)
    Atherothrombotic2 (13%)0
    Lacunar/other00
Concomitant disease:
    Hypertension9 (56%)6 (46%)
    Dyslipidemia3 (19%)2 (15%)
    Diabetes4 (25%)2 (15%)
    Atrial fibrillation13 (81%)10 (77%)
    Sick sinus syndrome01 (8%)
    Coronary heart disease2 (13%)1 (8%)
    Dilated cardiomyopathy1 (6%)0
    Valvular heart disease1 (6%)3 (23%)
  • Note:—IV indicates intravenous; rtPA, recombinant tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale.

  • * Data expressed as n (%) or mean ± SD.